Charles Theuer | President, CEO |
Scott Brown | CFO |
Maury Raycroft | Jefferies |
Soumit Roy | Jones Trading |
Bert Hazlett | BTIG |
Nick Abbott | Wells Fargo |
Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals' First Quarter 2021 Earnings Conference Call. [Operator Instructions.] During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, future expenses and cash runway and/or development plans and strategy. These statements are subject to various risks that are described in our filings made with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31st, 2020, and subsequent quarterly reports on Form 10-Q.
You are cautioned not to place undue reliance on these forward-looking statements, and we disclaim any obligation to update such statements.
Now I would like to turn the call over to Dr.